Report Detail

Request for Sample of this report

Service & Software Global AI Pathology Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4736184
    • |
  • 24 August, 2026
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global AI Pathology Software market size was valued at US$ 364 million in 2025 and is forecast to a readjusted size of US$ 571 million by 2032 with a CAGR of 6.6% during review period.
AI Pathology Software refers to software systems that utilize deep learning, computer vision, image recognition, digital pathology analysis, and medical knowledge models to perform automated recognition, quantitative analysis, and diagnostic support on pathological slides, whole-slide images (WSI), immunohistochemistry (IHC) images, cytology images, and molecular pathology data. These systems are used for applications such as tumor region identification, cell counting, tissue typing, lesion detection, grading and scoring, biomarker quantification, prognosis assessment, and treatment decision support. Their core objectives are to enhance diagnostic efficiency, reduce the manual workload of slide review, improve result consistency and reproducibility, and assist physicians in making more precise clinical judgments; they are widely deployed in hospital pathology departments, third-party medical testing laboratories, pharmaceutical R&D, clinical trials, and research institutions.
The global AI pathology software market is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. Driven by the widespread adoption of digital pathology equipment, strong R&D capabilities in medical AI, and demand for clinical trials, North American applications focus on AI-assisted cancer diagnosis, quantitative immunohistochemistry, drug development, and remote pathology consultation. The European market places greater emphasis on medical device approval, data compliance, clinical validation, and standardized diagnostic workflows. The Asia-Pacific region holds significant market potential, propelled by hospital digitalization, rising demand for cancer screening, a shortage of pathologists, and the development of "smart hospitals." The market is currently evolving from simple lesion detection toward comprehensive digital pathology platforms, multi-cancer diagnostic support, multimodal pathology analysis, and decision support for precision medicine. Future trends include automated whole-slide image analysis, AI-assisted tumor grading, the integration of pathology and genomic data, cloud-based remote pathology, companion diagnostics, and automated pathology analysis for clinical trials. Key challenges include the high cost of digital slide scanning equipment, difficulties in annotating pathology data, limited algorithm generalization capabilities, lengthy regulatory approval processes, complex hospital system integration, and varying levels of physician acceptance. The industry's average gross margin typically ranges from 55% to 80%; standardized software licensing and SaaS platforms command higher margins, whereas custom algorithm development, clinical validation, and system integration projects yield relatively lower margins.
This report is a detailed and comprehensive analysis for global AI Pathology Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Pathology Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Pathology Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Pathology Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Pathology Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Pathology Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Pathology Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, Inc., Paige AI, Inc., Indica Labs, Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Pathology Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Histopathology AI Analysis Software
Cytopathology AI Analysis Software
Immunohistochemistry AI Analysis Software
Molecular Pathology AI Analysis Software
Market segment by Processing Capacity
≤500 WSIs/Day
501–5,000 WSIs/Day
>5,000 WSIs/Day
Market segment by Application
Hospital Pathology Department
Third-party Medical Testing Laboratory
Pharmaceutical R&D
Market segment by players, this report covers
PathAI, Inc.
Paige AI, Inc.
Indica Labs
Aiforia Technologies Plc
Ibex Medical Analytics Ltd.
Proscia Inc.
Philips
Roche Diagnostics International Ltd
Leica Biosystems Nussloch GmbH
Fujifilm Holdings Corporation
Visiopharm A/S
Tempus AI, Inc.
Yitu Technology Co., Ltd.
Deepwise Healthcare Technology Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Pathology Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Pathology Software, with revenue, gross margin, and global market share of AI Pathology Software from 2021 to 2026.
Chapter 3, the AI Pathology Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Pathology Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Pathology Software.
Chapter 13, to describe AI Pathology Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of AI Pathology Software by Type
    • 1.3.1 Overview: Global AI Pathology Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global AI Pathology Software Consumption Value Market Share by Type in 2025
    • 1.3.3 Histopathology AI Analysis Software
    • 1.3.4 Cytopathology AI Analysis Software
    • 1.3.5 Immunohistochemistry AI Analysis Software
    • 1.3.6 Molecular Pathology AI Analysis Software
  • 1.4 Classification of AI Pathology Software by Processing Capacity
    • 1.4.1 Overview: Global AI Pathology Software Market Size by Processing Capacity: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global AI Pathology Software Consumption Value Market Share by Processing Capacity in 2025
    • 1.4.3 ≤500 WSIs/Day
    • 1.4.4 501–5,000 WSIs/Day
    • 1.4.5 >5,000 WSIs/Day
  • 1.5 Global AI Pathology Software Market by Application
    • 1.5.1 Overview: Global AI Pathology Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Hospital Pathology Department
    • 1.5.3 Third-party Medical Testing Laboratory
    • 1.5.4 Pharmaceutical R&D
  • 1.6 Global AI Pathology Software Market Size & Forecast
  • 1.7 Global AI Pathology Software Market Size and Forecast by Region
    • 1.7.1 Global AI Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.7.2 Global AI Pathology Software Market Size by Region, (2021-2032)
    • 1.7.3 North America AI Pathology Software Market Size and Prospect (2021-2032)
    • 1.7.4 Europe AI Pathology Software Market Size and Prospect (2021-2032)
    • 1.7.5 Asia-Pacific AI Pathology Software Market Size and Prospect (2021-2032)
    • 1.7.6 South America AI Pathology Software Market Size and Prospect (2021-2032)
    • 1.7.7 Middle East & Africa AI Pathology Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 PathAI, Inc.
    • 2.1.1 PathAI, Inc. Details
    • 2.1.2 PathAI, Inc. Major Business
    • 2.1.3 PathAI, Inc. AI Pathology Software Product and Solutions
    • 2.1.4 PathAI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 PathAI, Inc. Recent Developments and Future Plans
  • 2.2 Paige AI, Inc.
    • 2.2.1 Paige AI, Inc. Details
    • 2.2.2 Paige AI, Inc. Major Business
    • 2.2.3 Paige AI, Inc. AI Pathology Software Product and Solutions
    • 2.2.4 Paige AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Paige AI, Inc. Recent Developments and Future Plans
  • 2.3 Indica Labs
    • 2.3.1 Indica Labs Details
    • 2.3.2 Indica Labs Major Business
    • 2.3.3 Indica Labs AI Pathology Software Product and Solutions
    • 2.3.4 Indica Labs AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Indica Labs Recent Developments and Future Plans
  • 2.4 Aiforia Technologies Plc
    • 2.4.1 Aiforia Technologies Plc Details
    • 2.4.2 Aiforia Technologies Plc Major Business
    • 2.4.3 Aiforia Technologies Plc AI Pathology Software Product and Solutions
    • 2.4.4 Aiforia Technologies Plc AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Aiforia Technologies Plc Recent Developments and Future Plans
  • 2.5 Ibex Medical Analytics Ltd.
    • 2.5.1 Ibex Medical Analytics Ltd. Details
    • 2.5.2 Ibex Medical Analytics Ltd. Major Business
    • 2.5.3 Ibex Medical Analytics Ltd. AI Pathology Software Product and Solutions
    • 2.5.4 Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Ibex Medical Analytics Ltd. Recent Developments and Future Plans
  • 2.6 Proscia Inc.
    • 2.6.1 Proscia Inc. Details
    • 2.6.2 Proscia Inc. Major Business
    • 2.6.3 Proscia Inc. AI Pathology Software Product and Solutions
    • 2.6.4 Proscia Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Proscia Inc. Recent Developments and Future Plans
  • 2.7 Philips
    • 2.7.1 Philips Details
    • 2.7.2 Philips Major Business
    • 2.7.3 Philips AI Pathology Software Product and Solutions
    • 2.7.4 Philips AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Philips Recent Developments and Future Plans
  • 2.8 Roche Diagnostics International Ltd
    • 2.8.1 Roche Diagnostics International Ltd Details
    • 2.8.2 Roche Diagnostics International Ltd Major Business
    • 2.8.3 Roche Diagnostics International Ltd AI Pathology Software Product and Solutions
    • 2.8.4 Roche Diagnostics International Ltd AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Roche Diagnostics International Ltd Recent Developments and Future Plans
  • 2.9 Leica Biosystems Nussloch GmbH
    • 2.9.1 Leica Biosystems Nussloch GmbH Details
    • 2.9.2 Leica Biosystems Nussloch GmbH Major Business
    • 2.9.3 Leica Biosystems Nussloch GmbH AI Pathology Software Product and Solutions
    • 2.9.4 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Leica Biosystems Nussloch GmbH Recent Developments and Future Plans
  • 2.10 Fujifilm Holdings Corporation
    • 2.10.1 Fujifilm Holdings Corporation Details
    • 2.10.2 Fujifilm Holdings Corporation Major Business
    • 2.10.3 Fujifilm Holdings Corporation AI Pathology Software Product and Solutions
    • 2.10.4 Fujifilm Holdings Corporation AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Fujifilm Holdings Corporation Recent Developments and Future Plans
  • 2.11 Visiopharm A/S
    • 2.11.1 Visiopharm A/S Details
    • 2.11.2 Visiopharm A/S Major Business
    • 2.11.3 Visiopharm A/S AI Pathology Software Product and Solutions
    • 2.11.4 Visiopharm A/S AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Visiopharm A/S Recent Developments and Future Plans
  • 2.12 Tempus AI, Inc.
    • 2.12.1 Tempus AI, Inc. Details
    • 2.12.2 Tempus AI, Inc. Major Business
    • 2.12.3 Tempus AI, Inc. AI Pathology Software Product and Solutions
    • 2.12.4 Tempus AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Tempus AI, Inc. Recent Developments and Future Plans
  • 2.13 Yitu Technology Co., Ltd.
    • 2.13.1 Yitu Technology Co., Ltd. Details
    • 2.13.2 Yitu Technology Co., Ltd. Major Business
    • 2.13.3 Yitu Technology Co., Ltd. AI Pathology Software Product and Solutions
    • 2.13.4 Yitu Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Yitu Technology Co., Ltd. Recent Developments and Future Plans
  • 2.14 Deepwise Healthcare Technology Co., Ltd.
    • 2.14.1 Deepwise Healthcare Technology Co., Ltd. Details
    • 2.14.2 Deepwise Healthcare Technology Co., Ltd. Major Business
    • 2.14.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product and Solutions
    • 2.14.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global AI Pathology Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of AI Pathology Software by Company Revenue
    • 3.2.2 Top 3 AI Pathology Software Players Market Share in 2025
    • 3.2.3 Top 6 AI Pathology Software Players Market Share in 2025
  • 3.3 AI Pathology Software Market: Overall Company Footprint Analysis
    • 3.3.1 AI Pathology Software Market: Region Footprint
    • 3.3.2 AI Pathology Software Market: Company Product Type Footprint
    • 3.3.3 AI Pathology Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global AI Pathology Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global AI Pathology Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global AI Pathology Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global AI Pathology Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America AI Pathology Software Consumption Value by Type (2021-2032)
  • 6.2 North America AI Pathology Software Market Size by Application (2021-2032)
  • 6.3 North America AI Pathology Software Market Size by Country
    • 6.3.1 North America AI Pathology Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States AI Pathology Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada AI Pathology Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico AI Pathology Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe AI Pathology Software Consumption Value by Type (2021-2032)
  • 7.2 Europe AI Pathology Software Consumption Value by Application (2021-2032)
  • 7.3 Europe AI Pathology Software Market Size by Country
    • 7.3.1 Europe AI Pathology Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany AI Pathology Software Market Size and Forecast (2021-2032)
    • 7.3.3 France AI Pathology Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom AI Pathology Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia AI Pathology Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy AI Pathology Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific AI Pathology Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific AI Pathology Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific AI Pathology Software Market Size by Region
    • 8.3.1 Asia-Pacific AI Pathology Software Consumption Value by Region (2021-2032)
    • 8.3.2 China AI Pathology Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan AI Pathology Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea AI Pathology Software Market Size and Forecast (2021-2032)
    • 8.3.5 India AI Pathology Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia AI Pathology Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia AI Pathology Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America AI Pathology Software Consumption Value by Type (2021-2032)
  • 9.2 South America AI Pathology Software Consumption Value by Application (2021-2032)
  • 9.3 South America AI Pathology Software Market Size by Country
    • 9.3.1 South America AI Pathology Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil AI Pathology Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina AI Pathology Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa AI Pathology Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa AI Pathology Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa AI Pathology Software Market Size by Country
    • 10.3.1 Middle East & Africa AI Pathology Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey AI Pathology Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia AI Pathology Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE AI Pathology Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 AI Pathology Software Market Drivers
  • 11.2 AI Pathology Software Market Restraints
  • 11.3 AI Pathology Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 AI Pathology Software Industry Chain
  • 12.2 AI Pathology Software Upstream Analysis
  • 12.3 AI Pathology Software Midstream Analysis
  • 12.4 AI Pathology Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on AI Pathology Software. Industry analysis & Market Report on AI Pathology Software is a syndicated market report, published as Global AI Pathology Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Pathology Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo